Clinical Trials at Comprehensive Hematology Oncology
As of August 2026, 10 paid clinical trials are recruiting at Comprehensive Hematology Oncology, located at Comprehensive Hematology Oncology, 5000 Park St N #1017, St. Petersburg, FL 33709, phone (833) 421-0312 in St. Petersburg, Florida. Active studies at this site cover conditions such as Endometrial Cancer, Non-Small Cell Lung Cancer and Carcinoma, Non-Small-Cell Lung. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
10 clinical trials at Comprehensive Hematology Oncology
·Clear filters·Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Common conditions studied in St. Petersburg
- Endometrial Cancer (6 active studies)
- Non-Small Cell Lung Cancer (6 active studies)
- Carcinoma, Non-Small-Cell Lung (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Atopic Dermatitis (4 active studies)
- Geographic Atrophy (4 active studies)
Leading research sponsors in St. Petersburg
- Children's Oncology Group
- AstraZeneca
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in St. Petersburg?
There are approximately 224 recruiting clinical trials in St. Petersburg, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in St. Petersburg pay participants?
Most recruiting trials in St. Petersburg compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in St. Petersburg?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in St. Petersburg?
The most common conditions under active study in St. Petersburg include Endometrial Cancer (6), Non-Small Cell Lung Cancer (6), Carcinoma, Non-Small-Cell Lung (5), Acute Myeloid Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in St. Petersburg?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in St. Petersburg on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in St. Petersburg?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in St. Petersburg?
Recruiting research sites in St. Petersburg include Johns Hopkins All Children's Hospital, Comprehensive Hematology Oncology, Retina Vitreous Associates of Florida, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in St. Petersburg right now?
The largest active categories in St. Petersburg are Cancer & tumors (79), Eye & vision (17), Cardiovascular (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Comprehensive Hematology Oncology?
Comprehensive Hematology Oncology is located at Comprehensive Hematology Oncology, 5000 Park St N #1017, St. Petersburg, FL 33709. Use the Google Maps link in the intro above to get directions.
How do I contact Comprehensive Hematology Oncology?
You can reach Comprehensive Hematology Oncology by phone at (833) 421-0312. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.